Alendronate prevents femoral periprosthetic bone loss following total hip arthroplasty: Prospective randomized double-blind study

Journal of Orthopaedic Research

Volumn 24, Issue 7, 2006, Pages 1336-1341

  Arabmotlagh, Mohammad ^a   Rittmeister, Markus ^a   Hennings, Thorsten ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Alendronate; Bone loss; Bone remodeling; DEXA; Hip arthroplasty

Indexed keywords

ALENDRONIC ACID; ALKALINE PHOSPHATASE BONE ISOENZYME; CARBOXY TERMINAL TELOPEPTIDE; OSTEOCALCIN; PLACEBO;

ADULT; AGED; ARTICLE; BONE DENSITY; BONE MINERAL; BONE TURNOVER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG MECHANISM; DUAL ENERGY X RAY ABSORPTIOMETRY; ENDOPROSTHESIS LOOSENING; FEMALE; FEMUR; HIP OSTEOARTHRITIS; HUMAN; MAJOR CLINICAL STUDY; MALE; OSTEOLYSIS; POSTOPERATIVE CARE; PRIMARY PREVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; TOTAL HIP PROSTHESIS;

ADULT; AGED; ALENDRONATE; ALKALINE PHOSPHATASE; ARTHROPLASTY, REPLACEMENT, HIP; BONE DENSITY CONSERVATION AGENTS; BONE RESORPTION; COLLAGEN TYPE I; DOUBLE-BLIND METHOD; FEMALE; FEMUR; HIP PROSTHESIS; HUMANS; MALE; MIDDLE AGED; OSTEOCALCIN; OSTEOCLASTS; PEPTIDES; POSTOPERATIVE CARE; PROSPECTIVE STUDIES;

EID: 33746123524     PISSN: 07360266     EISSN: None     Source Type: Journal    
DOI: 10.1002/jor.20162     Document Type: Article

References (19)

1. Espehaug B, Havelin LI, Engesaeter LB, et al. 1997. Patient-related risk factors for early revision of total hip replacement. A population register-based case-control study of 674 revised hips. Acta Orthop 68:207-215.
2. Furnes O, Lie SA, Espehaug B, et al. 2001. Hip disease and the prognosis of total hip replacement. A review of 53698 primary total hip replacement reported to the Norwegian arthroplasty register 1987-99. J Bone Joint Surg 83[B]: 579-586.
3. Lewallen DG, Berry DJ. 1998. Periprosthetic fracture of the femur after total hip arthroplasty: Treatment and results to date. Instr Course Lect 47:243-249.
4. Kröger H, Venesmaa P, Jurvelin J, et al. 1998. Bone density at the proximal femur after total hip arthroplasty. Clin Orthop 352:66-74.
5. Petersen MB, Kolthoff N, Eiken P. 1995. Bone mineral density around femoral stems. DEXA measurements in 22 porous coated implants after 5 years. Acta Orthop Scand 66:432-434.
6. Pritchett JW. 1995. Femoral bone loss following hip replacement. A comparative study. Clin Orthop 314:156-161.
7. Rosenthall L, Bobyn JD, Brooks CE. 1999. Temporal changes of periprosthetic bone density in patients with a modular noncemented femoral prosthesis. J Arthroplasty 14:71-76.
8. Gruen TA, McNeice GM, Amstutz HC. 1979. Modes of failure of cemented stem-type femoral components. Clin Orthop 141:17-27.
9. Cohen B, Rushton N. 1995. Accuracy of DEXA measurement of bone mineral density after total hip arthroplasty. J Bone Joint Surg (Br) 77B:479-483.
10. Kiratli BJ, Heiner JP, McBeath AA, et al. 1992. Determination of bone mineral density by DEXA in patients with uncemented total hip arthroplasty. J Orthop Res 10:836-844.
11. Harris NJ, Lowman A, Wolsey L, et al. 2000. Changes in bone turnover and bone density after total hip arthroplasty. Hip Int 10:16-20.
12. Bobyn JD, Mortimer ES, Glassman AH, et al. 1992. Producing and avoiding stress shielding, laboratory and clinical observations of noncemented total hip arthroplasty. Clin Orthop 274:79-96.
13. Wolff J. 1892. Das Gesetz der Transformation der Knochen. Berlin: Hirschwald.
14. Blumsohn A, Eastell R. 1977. The performance and utility of biochemical markers of bone turn over: do we know enough to use them in clinical practice? Ann Clin Biochem 34:449.
15. Jensen JEB, Sorensen HA, Kollerup G, et al. 1994. Biological variation of biochemical bone markers. Scand J Clin Lab Invest 54(Suppl):36.
16. Dempster DW. 1995. Bone remodeling in osteoporosis. In: Riggs BL, Melton LJ, editors. Osteoporosis, etiology, diagnosis and management, 2nd ed. New York: Lippincott-Raven; p 67-92.
17. Wilkinson JM, Stockley I, Peel N, et al. 2001. Effect of pamidronate in preventing local bone loss after total hip arthroplasty: a randomized double-blind, controlled trial. J Bone Min Res 3:556-564.
18. Wilkinson JM, Hamer AJ, Rogers A, et al. 2003. Bone mineral density and biochemical markers of bone turnover in aseptic loosening after total hip arthroplasty. J Orthop Res 21:691-696.
19. Hennigs T, Arabmotlagh M, Schwarz A, et al. 2002. Dose dependent prevention of early periprosthetic bone loss by alendronate. Z Orthop 140:42-47.